Target to offer webinar on insecticide resistance

By

January 9, 2020

Target Specialty Products, a service provider of pest and turf and ornamental solutions in the United States and Canada, will hold its first Business Growth Webinar Series of 2020 on Friday, Jan. 24, at 10:30 a.m. PDT. The topic is “Battling Insecticide Resistance.”

Dr. Jamel Sandidge. PHOTO: NISUS CORP.

Dr. Jamel Sandidge. PHOTO: NISUS CORP.

Nisus Corp. has sponsored this month’s webinar. Dr. Jamel Sandidge, BCE, will share his knowledge about the biology of some pests and modes of action in the insecticides used.

His presentation will cover what resistance is and how it works for various actives, with the goal of helping attendees understand why product rotation with different modes of action is important when battling resistance.

Dr. Sandidge has served the pest control industry on multiple levels, including as a consultant, research entomologist and pest technician, for the past 18 years. Dr. Sandidge’s experience spans the practical understanding of owning a pest control business to developing knowledge through extensive education, research and development, and efficacy studies.

“We are thrilled to offer our customers another exciting webinar to educate them. ‘Battling Insecticide Resistance’ is such a hot topic, and we expect a record number in attendance for this month’s webinar,” says David Helt, president of Target Specialty Products.

Pest professionals can register for the webinar here.

Target’s Business Growth Webinar addressed insecticide formulations this past fall and solutions for tough summer pests and bed bugs this past summer. Click here to be added to Target’s mailing list and notified of future educational opportunities.

Headquartered in Santa Fe Springs, Calif., Target Specialty Products operates 44 locations across the United States and Canada.

Category:

About the Author

Ellen Kriz

Ellen Kriz is the managing editor for PMP magazine. She can be reached at ekriz@northcoastmedia.net or 216-706-3764.

Leave A Comment

Comments are closed.